[1]
Ugorji, W., Yang, G. and Jajoo, P. 2022. MicroRNAs as a Diagnostic Marker and a Therapeutic Target for Alzheimer’s Disease. Berkeley Pharma Tech Journal of Medicine. 2, 2 (Dec. 2022), 48–69.